- Home
- SCYX vs IOTR Comparison
SCYX vs IOTR Comparison
Compare SCYX & IOTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- IOTR
- Stock Information
- Founded
- SCYX 1999
- IOTR 2019
- Country
- SCYX United States
- IOTR Singapore
- Employees
- SCYX N/A
- IOTR N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- IOTR
- Sector
- SCYX Health Care
- IOTR
- Exchange
- SCYX Nasdaq
- IOTR NYSE
- Market Cap
- SCYX 36.8M
- IOTR 29.5M
- IPO Year
- SCYX 2014
- IOTR 2025
- Fundamental
- Price
- SCYX $0.74
- IOTR $0.41
- Analyst Decision
- SCYX
- IOTR
- Analyst Count
- SCYX 0
- IOTR 0
- Target Price
- SCYX N/A
- IOTR N/A
- AVG Volume (30 Days)
- SCYX 170.9K
- IOTR 465.4K
- Earning Date
- SCYX 08-07-2025
- IOTR 01-01-0001
- Dividend Yield
- SCYX N/A
- IOTR N/A
- EPS Growth
- SCYX N/A
- IOTR N/A
- EPS
- SCYX N/A
- IOTR N/A
- Revenue
- SCYX $2,630,000.00
- IOTR $9,578,336.00
- Revenue This Year
- SCYX $463.61
- IOTR N/A
- Revenue Next Year
- SCYX $310.80
- IOTR N/A
- P/E Ratio
- SCYX N/A
- IOTR N/A
- Revenue Growth
- SCYX N/A
- IOTR 13.93
- 52 Week Low
- SCYX $0.72
- IOTR $0.31
- 52 Week High
- SCYX $2.29
- IOTR $5.98
- Technical
- Relative Strength Index (RSI)
- SCYX 37.94
- IOTR N/A
- Support Level
- SCYX $0.72
- IOTR N/A
- Resistance Level
- SCYX $0.85
- IOTR N/A
- Average True Range (ATR)
- SCYX 0.05
- IOTR 0.00
- MACD
- SCYX -0.01
- IOTR 0.00
- Stochastic Oscillator
- SCYX 9.61
- IOTR 0.00
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.